Patients with rheumatoid arthritis in clinical remission and ultrasound-defined active synovitis exhibit higher disease activity and increased serum levels of angiogenic biomarkers

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  Ramírez, Julio ^a   Ruíz Esquide, Virginia ^a   Pomés, Isaac ^a   Celis, Raquel ^a   Cuervo, Andrea ^a   Hernández, M V ^a   Pomés, Jaume ^a   Pablos, José L ^b   Sanmartí, Raimon ^a   Cañete, Juan D ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b Universidad Complutense   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 2; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CXCL16 CHEMOKINE; FIBROBLAST GROWTH FACTOR 2; GELATINASE A; GELATINASE B; INTERLEUKIN 17F; INTERLEUKIN 18; INTERLEUKIN 20; INTERLEUKIN 23; INTERLEUKIN 33; INTERLEUKIN 6; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; PLACENTAL GROWTH FACTOR; PREDNISONE; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN D; ANTIRHEUMATIC AGENT;

ADULT; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DOPPLER FLOWMETRY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HYPERTROPHY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POWER DOPPLER ULTRASOUND; PROTEIN BLOOD LEVEL; REMISSION; RHEUMATOID ARTHRITIS; SYNOVIAL HYPERTROPHY; SYNOVITIS; ARTHRITIS, RHEUMATOID; BLOOD; ECHOGRAPHY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; REMISSION INDUCTION; SENSITIVITY AND SPECIFICITY; SYNOVITIS; ULTRASONOGRAPHY, DOPPLER;

EID: 84892183017     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4431     Document Type: Article

References (29)

1. Cañete JD, Pablos JL. Biologic therapy in rheumatoid arthritis. Curr Top Med Chem 2013, 13:752-759. 10.2174/15680266113139990093, 23574524.
2. Haavardsholm EA, Lie E, Lillegraven S. Should modern imaging be part of remission criteria in rheumatoid arthritis?. Best Pract Res Clin Rheumatol 2012, 26:767-785. 10.1016/j.berh.2012.10.004, 23273791.
3. Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 2006, 54:3761-3773. 10.1002/art.22190, 17133543.
4. Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008, 58:2958-2967. 10.1002/art.23945, 18821687.
5. Saleem B, Brown AK, Keen H, Nizam S, Freeston J, Karim Z, Quinn M, Wakefield R, Hensor E, Conaghan PG, Emery P. Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: a clinical and imaging comparative study. Arthritis Rheum 2009, 60:1915-1922. 10.1002/art.24596, 19565512.
6. Foltz V, Gandjbakhch F, Etchepare F, Rosenberg C, Tanguy ML, Rozenberg S, Bourgeois P, Fautrel B. Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity. Arthritis Rheum 2012, 64:67-76. 10.1002/art.33312, 21904998.
7. Taylor PC. VEGF and imaging of vessels in rheumatoid arthritis. Arthritis Res 2002, 4:S99-S107. 10.1186/ar582, 3240157, 12110128.
8. Scire CA, Montecucco C, Codullo V, Epis O, Todoerti M, Caporali R. Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. Rheumatology (Oxford) 2009, 48:1092-1097. 10.1093/rheumatology/kep171, 19561156.
9. Saleem B, Brown AK, Quinn M, Karim Z, Hensor EM, Conaghan P, Peterfy C, Wakefield RJ, Emery P. Can flare be predicted in DMARD treated RA patients in remission, and is it important? A cohort study. Ann Rheum Dis 2012, 71:1316-1321. 10.1136/annrheumdis-2011-200548, 22294638.
10. Gok M, Erdem H, Gogus F, Yilmaz S, Karadag O, Simsek I, Sagkan RI, Saglam M, Musabak U, Dinc A, Pay S. Relationship of ultrasonographic findings with synovial angiogenesis modulators in different forms of knee arthritides. Rheumatol Int 2013, 33:879-885. 10.1007/s00296-012-2452-y, 22811011.
11. Kurosaka D, Hirai K, Nishioka M, Miyamoto Y, Yoshida K, Noda K, Ukichi T, Yanagimachi M, Furuya K, Takahashi E, Kingetsu I, Fukuda K, Yamada A. Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis. J Rheumatol 2010, 37:1121-1128. 10.3899/jrheum.090941, 20436077.
12. Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D'Agostino MA, Sanchez EN, Iagnocco A, Schmidt WA, Bruyn GA, Kane D, OConnor PJ, Manger B, Joshua F, Koski J, Grassi W, Lassere MN, Swen N, Kainberger F, Klauser A, Ostergaard M, Brown AK, Machold KP, Conaghan PG, OMERACT 7 Special Interest Group Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 2005, 32:2485-2487. OMERACT 7 Special Interest Group.
13. Backhaus M, Burmester GR, Gerber T, Grassi W, Machold KP, Swen WA, Wakefield RJ, Manger B. Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis 2001, 60:641-649. 10.1136/ard.60.7.641, 1753749, 11406516.
14. Szkudlarek M, Court-Payen M, Jacobsen S, Klarlund M, Thomsen HS, Ostergaard M. Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum 2003, 48:955-962. 10.1002/art.10877, 12687537.
15. Quantibody: multiplex ELISA Array. [http://www.raybiotech.com].
16. Churchman SM, Geiler J, Parmar R, Horner EA, Church LD, Emery P, Buch MH, McDermott MF, Ponchel F. Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis: lack of sensitivity and interference by rheumatoid factor. Clin Exp Rheumatol 2012, 30:534-542.
17. Calcagno VMC. glmulti: an R Package for Easy Automated Model Selection with (Generalized) Linear Models. J Stat Software 2010, 34:1-29.
18. Ten Cate DF, Luime JJ, Swen N, Gerards AH, De Jager MH, Basoski NM, Hazes JM, Haagsma CJ, Jacobs JW. Role of ultrasonography in diagnosing early rheumatoid arthritis and remission of rheumatoid arthritis - a systematic review of the literature. Arthritis Res Ther 2013, 15:R4. 10.1186/ar4132, 3672772, 23298444.
19. Dougados M, Devauchelle-Pensec V, Ferlet JF, Jousse-Joulin S, D'Agostino MA, Backhaus M, Bentin J, Chales G, Chary-Valckenaere I, Conaghan P, Wakefield RJ, Etchepare F, Gaudin P, Grassi W, Heijde D, Mariette X, Naredo E, Szkudlarek M. The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound. Ann Rheum Dis 2013, 72:665-671. 10.1136/annrheumdis-2012-201469, 3618684, 22679298.
20. Mandl P, Naredo E, Wakefield RJ, Conaghan PG, D'Agostino MA. A systematic literature review analysis of ultrasound joint count and scoring systems to assess synovitis in rheumatoid arthritis according to the OMERACT filter. J Rheumatol 2011, 38:2055-2062. 10.3899/jrheum.110424, 21885517.
21. Filer A, de Pablo P, Allen G, Nightingale P, Jordan A, Jobanputra P, Bowman S, Buckley CD, Raza K. Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis. Ann Rheum Dis 2011, 70:500-507. 10.1136/ard.2010.131573, 3033529, 21115552.
22. Montecucco C, Todoerti M, Sakellariou G, Scire CA, Caporali R. Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis: results of a 12-month open-label randomised study. Arthritis Res Ther 2012, 14:R112. 10.1186/ar3838, 3446489, 22584017.
23. Todoerti M, Scire CA, Boffini N, Bugatti S, Montecucco C, Caporali R. Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritis. Ann N Y Acad Sci 2010, 1193:139-145. 10.1111/j.1749-6632.2009.05367.x, 20398020.
24. Cañete JD, Pablos JL, Sanmarti R, Mallofre C, Marsal S, Maymo J, Gratacos J, Mezquita J, Mezquita C, Cid MC. Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis. Arthritis Rheum 2004, 50:1636-1641. 10.1002/art.20181, 15146434.
25. Yoo SA, Yoon HJ, Kim HS, Chae CB, De Falco S, Cho CS, Kim WU. Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation. Arthritis Rheum 2009, 60:345-354. 10.1002/art.24289, 19180491.
26. Pablos JL, Santiago B, Galindo M, Torres C, Brehmer MT, Blanco FJ, Garcia-Lazaro FJ. Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immunol 2003, 170:2147-2152.
27. Ashraf S, Mapp PI, Walsh DA. Angiogenesis and the persistence of inflammation in a rat model of proliferative synovitis. Arthritis Rheum 2010, 62:1890-1898.
28. Izquierdo E, Cañete JD, Celis R, Santiago B, Usategui A, Sanmarti R, Del Rey MJ, Pablos JL. Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy. PLoS One 2009, 4:e8131. 10.1371/journal.pone.0008131, 2779850, 19956574.
29. Izquierdo E, Cañete JD, Celis R, Del Rey MJ, Usategui A, Marsal S, Sanmarti R, Criado G, Pablos JL. Synovial fibroblast hyperplasia in rheumatoid arthritis: clinicopathologic correlations and partial reversal by anti-tumor necrosis factor therapy. Arthritis Rheum 2011, 63:2575-2583. 10.1002/art.30433, 21547893.